Work in progress

Topics envisaged in 2023

  • The future of the Bayesian Biostatistics in the regulatory world, esp. EMA
  • Translational Bayesian / Ped extrapolation
  • Rare disease / Small population
  • Causal inference
  • Estimands
  • Diagnostic
  • Complex Innovative Designs
  • Bayesian biostatistics for Real World Evidence (RWE)
  • Meta-analyses, prior elicitation, historical controls, meta-analyses, indirect comparison
  • Bayesian inference in complex models (systems biology / PBPK / networks)
  • Bayesian Decision sciences / Benefit/Risk analyses and health economics
  • Non-Clinical Statistics, CMC and related topics (QbD, Stability, bioassays, validation, …)